Double‐Blind, Placebo‐Controlled Evaluation of Cinromide in Patients with the Lennox‐Gastaut Syndrome: The Group for the Evaluation of Cinromide in the Lennox‐Gastaut Syndrome

Epilepsia

Volumn 30, Issue 4, 1989, Pages 422-429

[No Author Info available]

Author keywords

Anticonvulsants; Cinromide; Clinical trials; Lennox Gastaut Syndrome; Placebo

Indexed keywords

ANTICONVULSIVE AGENT; CINROMIDE;

ADOLESCENT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LENNOX GASTAUT SYNDROME; MALE; MENTAL DEFICIENCY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; AGE FACTORS; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CINNAMATES; CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; HUMAN; MALE; PLACEBOS; RANDOM ALLOCATION; SYNDROME;

EID: 0024312464     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1989.tb05321.x     Document Type: Article

References (9)

1. On the subject of Lennox's “akinetic”petit mal; in memory of W. G. Lennox.
2. Childhood epileptic encephalopathy with diffuse slow spike‐waves (otherwise known as “petit mal variant”) or Lennox syndrome
3. The petit mal epilepsies, their treatment with trid‐ione
4. Clinical correlates of the fast and the slow spike‐wave electroencephalogram
5. Experimental anticonvulsant cinromide in monkey model: preliminary efficacy
6. Cinromide in the treatment of seizures in the Lennox‐Gastaut syndrome
7. Simultaneous determination of the anticonvulsants, cinromide (3‐bromo‐N‐ethylcinnamamide), 3‐bromocinnamamide, and carbamazepine in plasma by high‐performance liquid chromatography
8. The anticonvulsant activity of cinromide